RxDoctor Payments Data

Jill Quigley, MD

Family Medicine · Littleton, CONPI 1457480725

Payments from drug & device makers

$2,887in general payments, 2019–2025

Across 194 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$296
  • AstraZeneca$139
  • Pfizer$129
  • Merck$56
  • Biohaven Pharmaceutical Holding Company Ltd.$45
  • plus $355 from 17 others

What the payments were for

  • Food & beverage$2,887100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,887 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$88,289
Medicare patients
221
Services billed
1,049

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide35$48,668
JardianceEmpagliflozin17$28,977
Rosuvastatin Calcium214$3,154
SynthroidLevothyroxine Sodium20$2,030
Omega-3 Acid Ethyl Esters13$1,511
Ezetimibe75$1,412
Levothyroxine Sodium132$1,375
Omeprazole73$1,235
Atorvastatin Calcium109$1,216
Lisinopril133$995
Losartan Potassium75$858
Bupropion XlBupropion Hcl35$832
Metoprolol Succinate64$804
Gabapentin40$787
Zolpidem Tartrate26$589

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$34$48,66835 claims
Boehringer IngelheimJardiance$20$28,97717 claims
AbbVieSynthroid$1,868$2,03020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →